Proton beam therapy – the challenges of delivering high-quality evidence of clinical benefit
The use of proton beam therapy (PBT) offers the opportunity to improve greater conformality of radiotherapy treatment delivery in some patients. However, it is associated with a high capital cost and the need to build new dedicated facilities. We discuss how the global radiotherapy community can res...
Main Authors: | National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group, (CTRad) Proton Beam Clinical Trial Strategy Group, Amos, R, Bulbeck, H, Burnet, N, Crellin, A, Eaton, D, Evans, P, Hall, E, Hawkins, M, Kirby, K, Mackay, R, Sebag-Montefiore, D, Sharma, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2018
|
Similar Items
-
A minimal common outcome measure set for COVID-19 clinical research
by: WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection
Published: (2020) -
Early stage anal margin cancer: towards evidence‐based management
by: Renehan, A, et al.
Published: (2019) -
Clinical development of new drug-radiotherapy combinations.
by: Sharma, R, et al.
Published: (2016) -
Current opportunities to catalyze research in nutrition and cancer prevention - an interdisciplinary perspective
by: Cancer Research UK - Ludwig Cancer Research Nutrition And Cancer Prevention Collaborative Group
Published: (2019) -
Century-of-Information Research (CIR): a strategy for research and innovation in the Century of Information
by: The e-Science Directors' Forum Strategy Working Group
Published: (2008)